Sugarbreak offers a proprietary, all-natural system of herbal formulations designed to help reduce sugar consumption and promote healthy blood sugar management. The brand launched in September 2020 and is structured as a Public Benefit Corporation focused on reducing sugar consumption. Sugarbreak introduced three initial products—Resist, Stabilize, and Reduce—sold direct-to-consumer on Sugarbreak.com and Amazon. Its formulations are backed by over 20 ingredient clinical studies and the company is supported by notable medical professionals. The company plans to use new funding to expand availability and accelerate product development, with additional offerings targeted for early 2021. Founders include CEO Scarlett Leung along with Adam Lowry, Kyle Heller, and Luke Raymond.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2020